OBJECTIVES: In patients with inflammatory bowel diseases (IBDs), the presence of noncaseating mucosal granuloma is sufficient for diagnosing Crohn disease (CD) and may represent a specific immune response or microbial-host interaction. The cause of granulomas in CD is unknown and their association with the intestinal microbiota has not been addressed with high-throughput methodologies. METHODS: The mucosal microbiota from 3 different pediatric centers was studied with 454 pyrosequencing of the bacterial 16S rRNA gene and the fungal small subunit (SSU) ribosomal region in transverse colonic biopsy specimens from 26 controls and 15 treatment-naïve pediatric CD cases. Mycobacterium avium subspecies paratuberculosis (MAP) was tested with real-time polymerase chain reaction. The correlation of granulomatous inflammation with C-reactive protein was expanded to 86 treatment-naïve CD cases. RESULTS: The CD microbiota separated from controls by distance-based redundancy analysis (P = 0.035). Mucosal granulomata found in any portion of the intestinal tract associated with an augmented colonic bacterial microbiota divergence (P = 0.013). The granuloma-based microbiota separation persisted even when research center bias was eliminated (P = 0.04). Decreased Roseburia and Ruminococcus in granulomatous CD were important in this separation; however, principal coordinates analysis did not reveal partitioning of the groups. CRP levels >1 mg/dL predicted the presence of mucosal granulomata (odds ratio 28 [6-134.32]; 73% sensitivity, 91% specificity). CONCLUSIONS: Granulomatous CD associates with microbiota separation and C-reactive protein elevation in treatment-naïve children; however, overall dysbiosis in pediatric CD appears rather limited. Geographical/center bias should be accounted for in future multicenter microbiota studies.
OBJECTIVES: In patients with inflammatory bowel diseases (IBDs), the presence of noncaseating mucosal granuloma is sufficient for diagnosing Crohn disease (CD) and may represent a specific immune response or microbial-host interaction. The cause of granulomas in CD is unknown and their association with the intestinal microbiota has not been addressed with high-throughput methodologies. METHODS: The mucosal microbiota from 3 different pediatric centers was studied with 454 pyrosequencing of the bacterial 16S rRNA gene and the fungal small subunit (SSU) ribosomal region in transverse colonic biopsy specimens from 26 controls and 15 treatment-naïve pediatric CD cases. Mycobacterium avium subspecies paratuberculosis (MAP) was tested with real-time polymerase chain reaction. The correlation of granulomatous inflammation with C-reactive protein was expanded to 86 treatment-naïve CD cases. RESULTS: The CD microbiota separated from controls by distance-based redundancy analysis (P = 0.035). Mucosal granulomata found in any portion of the intestinal tract associated with an augmented colonic bacterial microbiota divergence (P = 0.013). The granuloma-based microbiota separation persisted even when research center bias was eliminated (P = 0.04). Decreased Roseburia and Ruminococcus in granulomatous CD were important in this separation; however, principal coordinates analysis did not reveal partitioning of the groups. CRP levels >1 mg/dL predicted the presence of mucosal granulomata (odds ratio 28 [6-134.32]; 73% sensitivity, 91% specificity). CONCLUSIONS:Granulomatous CD associates with microbiota separation and C-reactive protein elevation in treatment-naïve children; however, overall dysbiosis in pediatric CD appears rather limited. Geographical/center bias should be accounted for in future multicenter microbiota studies.
Authors: S E Dowd; J Delton Hanson; E Rees; R D Wolcott; A M Zischau; Y Sun; J White; D M Smith; J Kennedy; C E Jones Journal: J Wound Care Date: 2011-01 Impact factor: 2.072
Authors: Adrienne Lee; Tanya A Griffiths; Rohan S Parab; Robin K King; Marla C Dubinsky; Stefan J Urbanski; Iwona Wrobel; Kevin P Rioux Journal: J Pediatr Gastroenterol Nutr Date: 2011-02 Impact factor: 2.839
Authors: Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand Journal: Gastroenterology Date: 2010-10-08 Impact factor: 22.682
Authors: Paul Ryan; Raymond G Kelly; Garry Lee; J Kevin Collins; Gerald C O'Sullivan; Joe O'Connell; Fergus Shanahan Journal: Am J Gastroenterol Date: 2004-08 Impact factor: 10.864
Authors: Michael T Bailey; James C Walton; Scot E Dowd; Zachary M Weil; Randy J Nelson Journal: Brain Behav Immun Date: 2010-01-04 Impact factor: 7.217
Authors: Nitsan Maharshak; Christopher D Packey; Melissa Ellermann; Sayeed Manick; Jennica P Siddle; Eun Young Huh; Scott Plevy; R Balfour Sartor; Ian M Carroll Journal: Gut Microbes Date: 2013-06-20
Authors: Dorottya Nagy-Szakal; Sabina A V Mir; Matthew C Ross; Nina Tatevian; Joseph F Petrosino; Richard Kellermayer Journal: J Pediatr Gastroenterol Nutr Date: 2013-05 Impact factor: 2.839
Authors: Rajesh Shah; Julia L Cope; Dorottya Nagy-Szakal; Scot Dowd; James Versalovic; Emily B Hollister; Richard Kellermayer Journal: Gut Microbes Date: 2016-05-23
Authors: Naamah L Zitomersky; Benjamin J Atkinson; Sarah W Franklin; Paul D Mitchell; Scott B Snapper; Laurie E Comstock; Athos Bousvaros Journal: PLoS One Date: 2013-06-11 Impact factor: 3.240
Authors: Sabina A Mir; Dorottya Nagy-Szakal; Scot E Dowd; Reka G Szigeti; C Wayne Smith; Richard Kellermayer Journal: PLoS One Date: 2013-08-19 Impact factor: 3.240
Authors: R Alan Harris; Dorottya Nagy-Szakal; Sabina A V Mir; Eibe Frank; Reka Szigeti; Jess L Kaplan; Jiri Bronsky; Antone Opekun; George D Ferry; Harland Winter; Richard Kellermayer Journal: Epigenetics Date: 2014-06-17 Impact factor: 4.528